Charles C O'Connor from New Orleans, LA, age 58

License Records

Charles F O'connor

License #:

28327 - Expired

Category:

Health Care

Effective Date:

Jan 1, 1992

Expiration Date:

Dec 31, 1991

Type:

Radiologic Technology

Lawyers & Attorneys

Charles O'Connor - Lawyer

view source

ISLN:

910674933

Admitted:

1995

University:

Hofstra University

Charles O'Connor - Lawyer

view source

Office:

Dentons US LLP

Specialties:

International Law
Real Estate
Government Contracts
Environmental Regulation
Chemical Regulation

ISLN:

904739334

Admitted:

1967

University:

Georgetown University, M.A., 1985; Harvard University, A.B., 1964

Law School:

Georgetown University, J.D., 1967

Charles O'Connor - Lawyer

view source

Specialties:

Environmental Law
Litigation
Zoning, Planning and Land Use

ISLN:

904739297

Admitted:

1958

University:

Loyola University, B.S., 1954

Law School:

Loyola University, J.D., 1958

Name / Title

Company / Classification

Phones & Addresses

Charles E. O'connor

MCLEOD-BISHOP SYSTEMS, INC

Charles O'connor
President, Director

CHARLES O'CONNOR INC

3458 High Vis Dr, Dallas, TX 75234

Charles O'connor

LOCO PARTY, LLC

24 Timberline Dr, Roanoke, TX 76262

Medicine Doctors

Charles M. O'connor

view source

Specialties:

Gastroenterology

Work:

Gastrointestinal Associates
801 N Weisgarber Rd STE 100, Knoxville, TN 37909
865 622-3442 (phone)

Gastrointestinal Associates
629 Delozier Way STE 100, Powell, TN 37849
865 947-1161 (phone), 865 558-0658 (fax)

Gastrointestinal Associates
11440 Parkside Dr STE 200, Knoxville, TN 37934
865 588-5121 (phone)

Education:

Medical School
University of South Florida College of Medicine at Tampa
Graduated: 1985

Procedures:

Colonoscopy
Esophageal Dilatation
Hemorrhoid Procedures
Sigmoidoscopy
Upper Gastrointestinal Endoscopy

Conditions:

Gastritis and Duodenitis
Hemorrhoids
Inflammatory Bowel Disease (IBD)
Abdominal Hernia
Acute Pancreatitis

Languages:

English
Spanish

Description:

Dr. O'connor graduated from the University of South Florida College of Medicine at Tampa in 1985. He works in Knoxville, TN and 2 other locations and specializes in Gastroenterology. Dr. O'connor is affiliated with North Knoxville Medical Center and Physicians Regional Medical Center.

Charles Timothy O'Connor

view source

Specialties:

Psychiatry

Education:

Louisiana State University at New Orleans (1961)

Us Patents

Sequential Synthesis Of Core-Shell Nanoparticles Using Reverse Micelles
view source
US Patent:

20020068187, Jun 6, 2002
Filed:

Apr 9, 2001
Appl. No.:

09/829401
Inventors:

Charles O'Connor - New Orleans LA, US
Everett Carpenter - Washington DC, US
Jessica Sims - Slidell LA, US
International Classification:

B05D003/02
B32B005/16
B32B009/00
US Classification:

428/546000, 428/403000, 427/372200
Abstract:

By utilizing the sequential synthesis afforded reverse micelles, nanocomposite materials can be synthesized which have a diamagnetic core surrounded by a thin shell of ferromagnetic material passivated with a second shell of a diamagnet. Using gold as the diamagnetic material and iron as the ferromagnetic material, nanocomposites can be synthesized where there is a thin layer of the magnetic material, which is passivated and protected from oxidation. In this case, all of the spins of the magnetic layer lie within the surface of the particle.

Reagent For Labeling Primary Amine Groups In Proteins
view source
US Patent:

20140342388, Nov 20, 2014
Filed:

Mar 29, 2014
Appl. No.:

14/229911
Inventors:

Yang Cai - New Orleans LA, US
Matthew A. Tarr - Metairie LA, US
Ujwal S. Patil - New Orleans LA, US
Haiou Qu - Little Rock AR, US
Daniela Caruntu - Mount Pleasant MI, US
Charles J. O'Connor - New Orleans LA, US
International Classification:

G01N 33/58
G01N 33/68
US Classification:

435 29, 436 89
Abstract:

A reagent includes a magnetic nanoparticle, a cleavable linker, and a primary amine reactive group. A first end of the cleavable linker may conjugate to a surface of the magnetic nanoparticle. A second end of the cleavable linker may conjugate to a primary amine reactive group. A method of using the reagent includes adding the reagent to a native protein mixture such that magnetic nanoparticles may conjugate to the protein with exposed primary amine groups in the native protein mixture. The method also includes separating the proteins with exposed primary amine group from other components of the native protein mixture under a magnetic field. The method further includes removing the magnetic nanoparticles from the proteins with the exposed primary amine groups from at cleavable linkers. The method finally includes identifying sequences and/or sites of the exposed primary amine groups in the proteins.